A new drug that significantly lowers "stubborn" blood pressure is on the horizon, following the results of its Phase III clinical trial. The treatment, called baxdrostat, has been hailed as the most promising advance in hypertension management in decades, demonstrating the ability to help patients whose blood pressure remains dangerously high despite standard therapy. Continue Reading Category:Heart Disease, Illnesses and conditions, Body and Mind Tags:University College London, Blood Pressur...
